Case Study

Specifar

Specifar is a Greek pharmaceutical company active in the development, production, and marketing of generic and specialized medicines. Founded in 1985, it expanded internationally through exports and partnerships. Since 2011 it has been part of the international pharmaceutical group Watson/Actavis, now part of Teva.

ΕΣΠΑ Ελλάδα 2.0 — Με τη χρηματοδότηση της Ευρωπαϊκής Ένωσης NextGenerationEU